Literature DB >> 15724942

Pathophysiology of bone cancer pain.

Mary Ann C Sabino1, Patrick W Mantyh.   

Abstract

The most common cancers, such as those affecting the breast, prostate, and lung have a strong predilection to metastasize to bone. Bone metastasis frequently results in pain, pathologic fractures, hypercalcemia, and spinal cord compression. Pain can have a devastating effect on the quality of life in advanced cancer patients and is a serious complication of cancer. Although significant advances are being made in cancer treatment and diagnosis, the basic neurobiology of bone cancer pain is poorly understood. New insights into the mechanisms that induce cancer pain now are coming from animal models. Chemicals derived from tumor cells, inflammatory cells, and cells derived from bone appear to be involved simultaneously in driving this frequently difficult-to-control pain state. Understanding the mechanisms involved in the pathophysiology of bone cancer pain will improve both our ability to provide mechanism-based therapies and the quality of life of cancer patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15724942

Source DB:  PubMed          Journal:  J Support Oncol        ISSN: 1544-6794


  36 in total

Review 1.  Acupuncture for the treatment of cancer pain: a systematic review of randomised clinical trials.

Authors:  Tae-Young Choi; Myeong Soo Lee; Tae-Hun Kim; Christopher Zaslawski; Edzard Ernst
Journal:  Support Care Cancer       Date:  2012-03-25       Impact factor: 3.603

Review 2.  Palliative radiation therapy for canine osteosarcoma.

Authors:  Monique N Mayer; Candace K Grier
Journal:  Can Vet J       Date:  2006-07       Impact factor: 1.008

Review 3.  Clinical efficacy of denosumab versus bisphosphonates for the prevention of bone complications: implications for nursing.

Authors:  Cynthia Campbell-Baird; Stacey Harrelson; Georgette Frey; Arun Balakumaran
Journal:  Support Care Cancer       Date:  2015-08-23       Impact factor: 3.603

4.  Bisphosphonate therapy in multiple myeloma in preventing vertebral collapses: preliminary report.

Authors:  Francesco C Tamburrelli; L Proietti; L Scaramuzzo; V De Stefano; C A Logroscino
Journal:  Eur Spine J       Date:  2012-03-21       Impact factor: 3.134

5.  Formaldehyde up-regulates TRPV1 through MAPK and PI3K signaling pathways in a rat model of bone cancer pain.

Authors:  Ying Han; Yan Li; Xing Xiao; Jia Liu; Xiang-Ling Meng; Feng-Yu Liu; Guo-Gang Xing; You Wan
Journal:  Neurosci Bull       Date:  2012-04       Impact factor: 5.203

Review 6.  Mechanisms that drive bone pain across the lifespan.

Authors:  Patrick W Mantyh
Journal:  Br J Clin Pharmacol       Date:  2018-11-22       Impact factor: 4.335

7.  Tumor tissue-derived formaldehyde and acidic microenvironment synergistically induce bone cancer pain.

Authors:  Zhiqian Tong; Wenhong Luo; Yanqing Wang; Fei Yang; Ying Han; Hui Li; Hongjun Luo; Bo Duan; Tianle Xu; Qiliang Maoying; Huangying Tan; Jun Wang; Hongmei Zhao; Fengyu Liu; You Wan
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

Review 8.  Animal models of cancer pain.

Authors:  Cholawat Pacharinsak; Alvin Beitz
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

Review 9.  Metastatic bone pain: treatment options with an emphasis on bisphosphonates.

Authors:  Roger von Moos; Florian Strasser; Silke Gillessen; Kathrin Zaugg
Journal:  Support Care Cancer       Date:  2008-08-06       Impact factor: 3.603

10.  Use of non-opioid analgesics as adjuvants to opioid analgesia for cancer pain management in an inpatient palliative unit: does this improve pain control and reduce opioid requirements?

Authors:  Shivani Shinde; Pamela Gordon; Prashant Sharma; James Gross; Mellar P Davis
Journal:  Support Care Cancer       Date:  2014-08-29       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.